Literature DB >> 10195930

Poor glycemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy.

S Lehto1, T Rönnemaa, K Pyörälä, M Laakso.   

Abstract

Patients with type 1 diabetes mellitus, especially those with nephropathy, are at increased risk for coronary heart disease (CHD). However, information on the predictive value of cardiovascular risk factors and the degree of hyperglycemia with respect to CHD events in patients with type 1 diabetes without nephropathy is still incomplete. Therefore, we performed a prospective study on risk factors for CHD in patients with type 1 diabetes free of clinical nephropathy. At baseline examination, cardiovascular risk factor levels of CHD were determined in 177 patients with type 1 diabetes (87 men and 90 women), age 45 to 64 years at baseline and >/=30 years at the time of diagnosis of diabetes. These patients were followed up to 7 years with respect to CHD events. Altogether, 20 patients with type 1 diabetes (13 men [7.3%] and 7 women [3.9%]) died of CHD and 28 patients with type 1 diabetes (17 men [9.6%] and 11 women [6.2%]) had a serious CHD event (death from CHD or nonfatal myocardial infarction). In multivariate Cox regression analysis, a previous history of myocardial infarction (hazard ratio [HR] and its 95% confidence interval, 8.0 [3.1 to 21.0], P<0.001), high glycohemoglobin A1 (>10.4%, the highest tertile, HR 5.4 [1.4 to 20.4], P=0.013), and the duration of diabetes (>16 years, the highest tertile, HR 4.2 [1.3 to 12.9], P=0.013) were the only variables associated with CHD death even after adjustment for other cardiovascular risk factors. These variables also predicted the incidence of all CHD events. Our results indicate that poor metabolic control is a strong predictor of CHD events in patients with late-onset type 1 diabetes without nephropathy, independently of other cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10195930     DOI: 10.1161/01.atv.19.4.1014

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  20 in total

1.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

Review 2.  Diabetic vascular disease and the potential role of macrophage glucose metabolism.

Authors:  Tomohiro Nishizawa; Karin E Bornfeldt
Journal:  Ann Med       Date:  2011-06-17       Impact factor: 4.709

3.  Glycemia and cardiovascular risk: challenging evidence based medicine.

Authors:  K Kitsios; A Tsapas; P Karagianni
Journal:  Hippokratia       Date:  2011-07       Impact factor: 0.471

4.  Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes?

Authors:  Baqiyyah Conway; Tina Costacou; Trevor Orchard
Journal:  Diab Vasc Dis Res       Date:  2009-08-04       Impact factor: 3.291

Review 5.  Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?

Authors:  K Dahl-Jørgensen; J R Larsen; K F Hanssen
Journal:  Diabetologia       Date:  2005-06-22       Impact factor: 10.122

6.  The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.

Authors:  Patricia A Cleary; Trevor J Orchard; Saul Genuth; Nathan D Wong; Robert Detrano; Jye-Yu C Backlund; Bernard Zinman; Alan Jacobson; Wanjie Sun; John M Lachin; David M Nathan
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

7.  Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR).

Authors:  Katarina Eeg-Olofsson; Jan Cederholm; Peter M Nilsson; Björn Zethelius; Ann-Marie Svensson; Soffia Gudbjörnsdóttir; Björn Eliasson
Journal:  Diabetes Care       Date:  2010-04-27       Impact factor: 19.112

8.  Endothelial function and arterial stiffness in uncomplicated type 1 diabetes and healthy controls and the impact of insulin on these parameters during an euglycemic clamp.

Authors:  Birgit Wilhelm; Matthias M Weber; Hans Peter Kreisselmeier; Matthias Kugler; Claudius Ries; Andreas Pfützner; Peter H Kann; Thomas Forst
Journal:  J Diabetes Sci Technol       Date:  2007-07

9.  Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes.

Authors:  E S Kilpatrick; A S Rigby; S L Atkin
Journal:  Diabetologia       Date:  2007-11-27       Impact factor: 10.122

10.  A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.

Authors:  Johan Wadén; Carol Forsblom; Lena M Thorn; Daniel Gordin; Markku Saraheimo; Per-Henrik Groop
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.